Details of the Drug

General Information of Drug (ID: DM6Y702)

Drug Name

GLS-1200

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04408183) GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel. U.S. National Institutes of Health.